MicroRNA expression profiles of LO2 cells expressing the wild-type and mutant HBx gene

Fu,Xiaoyu; Tan,Deming; Hou,Zhouhua; Hu,Zhiliang; Liu,Guozhen; Ouyang,Yi; Liu,Fei

doi:10.3892/mmr.2012.1203

MicroRNA expression profiles of LO2 cells expressing the wild-type and mutant HBx gene

Authors:
- Xiaoyu Fu
- Deming Tan
- Zhouhua Hou
- Zhiliang Hu
- Guozhen Liu
- Yi Ouyang
- Fei Liu
View Affiliations

Affiliations: Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China, Department of Infectious Diseases, The Second Hospital of Nanjing, Nanjing, Jiangsu 210000, P.R. China
Published online on: November 26, 2012 https://doi.org/10.3892/mmr.2012.1203
Pages: 633-641

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. Although numerous studies have suggested the potentially oncogenic roles of wild‑type or mutant hepatitis B virus X (HBx) protein in hepatocarcinogenesis, their exact mechanism remains unclear. Increasing evidence suggests that microRNAs (miRNAs) play essential roles in embryogenesis, cell differentiation and carcinogenesis. This study aimed to investigate the effect of HBx on the miRNA expression profile of LO2 cells. We established the LO2 cell line transfected with recombinant plasmid pcDNA3.0/HBx-d382, pcDNA/HBx and plasmid pcDNA3.0 using Lipofectamine™ 2000, which was confirmed by reverse transcription‑polymerase chain reaction (RT-PCR) and western blotting. We then demonstrated the miRNA expression profiles in the stably transfected LO2 cells using a mammalian miRNA microarray containing whole‑human mature and precursor miRNA sequences. The results were confirmed by real-time quantitative PCR (qPCR). RT-PCR and western blot analysis showed that a stably HBx‑transfected LO2 cell line had been successfully established. According to the microarray, compared to LO2/pcDNA3.0 cells, 6 miRNAs were shown to have higher expression and 5 were shown to have decreased expression in LO2/HBx-d382 cells, while 4 up- and 12 downregulated miRNAs were observed in LO2/HBx cells. There were 8 different expression patterns of miRNAs between LO2/HBx and LO2/HBx-d382 cells. All the chip results were consistent with the real‑time PCR data. Consequently, the HBx gene may influence the miRNA expression profile of LO2 cells. Thus, it may be helpful to further investigate the role of HBx in hepatocarcinogenesis and clarify the underlying molecular mechanisms involved.

View Figures

View References

1	Farazi PA and DePinho RA: Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 6:674–687. 2006. View Article : Google Scholar : PubMed/NCBI
2	Parkin DM, Bray FI and Devesa SS: Cancer burden in the year 2000. The global picture. Eur J Cancer. 37:S4–S66. 2001.PubMed/NCBI
3	Wang WL, London WT, Lega L and Feitelson MA: HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology. 14:29–37. 1991. View Article : Google Scholar : PubMed/NCBI
4	Tang H, Oishi N, Kaneko S and Murakami S: Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci. 97:977–983. 2006. View Article : Google Scholar : PubMed/NCBI
5	Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D and Bréchot C: Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene. 18:4848–4859. 1999. View Article : Google Scholar : PubMed/NCBI
6	Yu DY, Moon HB, Son JK, et al: Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol. 31:123–132. 1999. View Article : Google Scholar : PubMed/NCBI
7	Liu XH, Lin J, Zhang SH, et al: COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma. World J Gastroenterol. 14:1346–1352. 2008. View Article : Google Scholar : PubMed/NCBI
8	Ma NF, Lau SH, Hu L, et al: COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Clin Cancer Res. 14:5061–5068. 2008. View Article : Google Scholar : PubMed/NCBI
9	Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
10	Budhu A, Jia HL, Forgues M, et al: Identification of metastasis-related micro-RNAs in hepatocellular carcinoma. Hepatology. 47:897–907. 2008. View Article : Google Scholar
11	Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST and Patel T: Micro-RNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
12	Huang J, Wang Y, Guo Y and Sun S: Downregulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology. 52:60–70. 2010. View Article : Google Scholar : PubMed/NCBI
13	Zhu P, Tan D, Peng Z, Liu F and Song L: Polymorphism analyses of hepatitis B virus X gene in hepatocellular carcinoma patients from southern China. Acta Biochim Biophys Sin (Shanghai). 39:265–272. 2007. View Article : Google Scholar : PubMed/NCBI
14	Boyle P and Levin B: World Cancer Report 2008. International Agency for Research on Cancer; Lyons, France: pp. 338–343. 2008
15	Andrisani OM and Barnabas S: The role of the transcriptional involvement of HBV pX in hepatocarcinogenesis (Review). Int J Oncol. 15:373–139. 1999.
16	Chen HY, Tang NH, Lin N, Chen ZX and Wang XZ: Hepatitis B virus X protein induces apoptosis and cell cycle deregulation through interfering with DNA repair and checkpoint responses. Hepatol Res. 38:174–182. 2008.PubMed/NCBI
17	Chen S, Zhao W, Tan W, et al: Association of TBX21 T-1993C polymorphism with viral persistence but not disease progression in hepatitis B virus carrier. Hepatol Res. 39:716–723. 2009. View Article : Google Scholar : PubMed/NCBI
18	Carleton M, Cleary MA and Linsley PS: MicroRNAs and cell cycle regulation. Cell Cycle. 6:2127–2132. 2007. View Article : Google Scholar : PubMed/NCBI
19	Vebtura A and Jacka T: MicroRNAs and cancer: short RNAs go a long way. Cell. 136:586–591. 2009. View Article : Google Scholar : PubMed/NCBI
20	Masaki T: MicroRNA and hepatocellular carcinoma. Hepatol Res. 39:751–752. 2009. View Article : Google Scholar : PubMed/NCBI
21	Huang XH, Wang Q, Chen JS, et al: Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. Hepatol Res. 39:786–794. 2009. View Article : Google Scholar : PubMed/NCBI
22	Simon DJ, Madison JM, Conery AL, et al: The microRNA miR-1 regulates a MEF-2 dependent retrograde signal at neuromuscular junctions. Cell. 133:903–915. 2008. View Article : Google Scholar : PubMed/NCBI
23	Nasser MW, Datta J, Nuovo G, et al: Downregulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem. 283:33394–33405. 2008. View Article : Google Scholar : PubMed/NCBI
24	Sarver AL, French AJ, Borralho PM, et al: Human colon cancer profiles show differential MicroRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer. 9:4012009. View Article : Google Scholar
25	Datta J, Kutay H, Nasser MW, et al: Methylation mediated silencing of Micro-RNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res. 68:5049–5058. 2008. View Article : Google Scholar : PubMed/NCBI
26	Jung JK, Arora P, Pagano JS and Jang KL: Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK4/6-pRb-E2F1 pathway. Cancer Res. 67:5771–5778. 2007. View Article : Google Scholar : PubMed/NCBI
27	Yu J, Ohuchida K, Mizumoto K, et al: MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol Cancer. 9:1692010. View Article : Google Scholar : PubMed/NCBI
28	Hurteau GJ, Carlson JA, Spivack SD and Brock GJ: Overexpression of the MicroRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 67:7972–7976. 2007. View Article : Google Scholar : PubMed/NCBI
29	Park SM, Gaur AB, Lengyel E and Peter ME: The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
30	Yang SZ, Zhang LD, Zhang Y, et al: HBx protein induces EMT through c-Src activation in SMMC-7721 hepatoma cell line. Biochem Biophys Res Commun. 382:555–560. 2009. View Article : Google Scholar : PubMed/NCBI
31	Vrba L, Jensen TJ, Garbe JC, et al: Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS One. 5:e86972010. View Article : Google Scholar : PubMed/NCBI
32	Pekarsky Y, Santanam U, Cimmino A, et al: Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 66:11590–11593. 2006. View Article : Google Scholar : PubMed/NCBI
33	Fabbri M, Garzon R, Cimmino A, et al: MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A. 104:15805–15810. 2007. View Article : Google Scholar : PubMed/NCBI
34	Park SY, Lee JH, Ha M, Nam JW and Kim VN: miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol. 16:23–29. 2009. View Article : Google Scholar : PubMed/NCBI
35	Kefas B, Godlewski L, Comeau L, et al: MicroRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is downregulated in glioblastoma. Cancer Res. 68:3566–3572. 2008. View Article : Google Scholar : PubMed/NCBI
36	Silber J, Lim DA, Petritsch C, et al: miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 6:142008. View Article : Google Scholar : PubMed/NCBI
37	Takada Y, Murakami A and Aggarwal BB: Zerumbone abolishes NF-κB and IκBα kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis and downregulation of invasion. Oncogene. 24:6957–6969. 2005.